4.7 Article

Overexpression of VIRMA confers vulnerability to breast cancers via the m6A-dependent regulation of unfolded protein response

期刊

出版社

SPRINGER BASEL AG
DOI: 10.1007/s00018-023-04799-4

关键词

N-6-methyladenosine (m(6)a); Messenger RNA; VIRMA; Unfolded protein response; Endoplasmic reticulum stress; Breast cancer

向作者/读者索取更多资源

Virilizer-like m(6)A methyltransferase-associated protein (VIRMA) is critical for RNA m(6)A deposition, but its aberrant expression in human diseases is not well understood. We found that VIRMA is amplified and overexpressed in 15-20% of breast cancers. The nuclear-enriched full-length VIRMA promotes m(6)A-dependent breast tumourigenesis, while the cytoplasmic-localised N-terminal VIRMA does not. VIRMA overexpression upregulates the m(6)A-modified long non-coding RNA NEAT1, contributing to breast cancer cell growth.
Virilizer-like m(6)A methyltransferase-associated protein (VIRMA) maintains the stability of the m(6)A writer complex. Although VIRMA is critical for RNA m(6)A deposition, the impact of aberrant VIRMA expression in human diseases remains unclear. We show that VIRMA is amplified and overexpressed in 15-20% of breast cancers. Of the two known VIRMA isoforms, the nuclear-enriched full-length but not the cytoplasmic-localised N-terminal VIRMA promotes m(6)A-dependent breast tumourigenesis in vitro and in vivo. Mechanistically, we reveal that VIRMA overexpression upregulates the m(6)A-modified long non-coding RNA, NEAT1, which contributes to breast cancer cell growth. We also show that VIRMA overexpression enriches m(6)A on transcripts that regulate the unfolded protein response (UPR) pathway but does not promote their translation to activate the UPR under optimal growth conditions. Under stressful conditions that are often present in tumour microenvironments, VIRMA-overexpressing cells display enhanced UPR and increased susceptibility to death. Our study identifies oncogenic VIRMA overexpression as a vulnerability that may be exploited for cancer therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据